(Total Views: 789)
Posted On: 10/11/2020 4:41:10 AM
Post# of 149272
Re: ClosetInvestor #60727
NASH would have been the best choice
Because the trial is only 1/2 a year and any positive results in the indication would have exploded the share price. The biotech world is anxiously awaiting a drug that shows promise for the disease.
Because the trial is only 1/2 a year and any positive results in the indication would have exploded the share price. The biotech world is anxiously awaiting a drug that shows promise for the disease.
(5)
(0)Scroll down for more posts ▼
